Brother/sister siblings affected with Hunter disease: evidence for skewed X chromosome inactivation
- PMID: 9611068
- DOI: 10.1111/j.1399-0004.1998.tb02654.x
Brother/sister siblings affected with Hunter disease: evidence for skewed X chromosome inactivation
Abstract
Hunter disease is an X-linked recessive disorder caused by a deficiency of iduronate-2-sulfatase activity. We describe a pair of brother/sister siblings with a typical feature of Hunter disease (mucopolysaccharidosis type II). They had normal karyotypes but a marked deficiency of iduronate-2-sulfatase activity in both lymphocytes and fibroblasts. The molecular analysis of the iduronate-2-sulfatase gene revealed the R468L(G1403-->T) substitution in their genes. Although the sister's genomic DNA was heterozygous for the mutant allele, the sister's cDNA was found to be homogeneous for this mutation. The mother was found to be a heterozygote. The analysis of X chromosome inactivation by comparison of the methylation patterns of the androgen-receptor (AR) gene which was isolated from the sister's fibroblasts and leucocytes revealed a skewed X chromosome inactivation of the paternal allele. These findings indicate that a skewed X chromosome inactivation of the paternal gene and a point mutation in the maternal gene were responsible for the lack of iduronate-2-sulfatase activity in the sister.
Similar articles
-
Hunter disease in a girl caused by R468Q mutation in the iduronate-2-sulfatase gene and skewed inactivation of the X chromosome carrying the normal allele.Hum Mutat. 1997;10(5):361-7. doi: 10.1002/(SICI)1098-1004(1997)10:5<361::AID-HUMU5>3.0.CO;2-I. Hum Mutat. 1997. PMID: 9375851
-
Mucopolysaccharidosis type II in a female carrying a heterozygous stop mutation of the iduronate-2-sulfatase gene and showing a skewed X chromosome inactivation.Eur J Med Genet. 2013 Mar;56(3):159-62. doi: 10.1016/j.ejmg.2012.11.006. Epub 2012 Dec 8. Eur J Med Genet. 2013. PMID: 23232253
-
Intermediate form of mucopolysaccharidosis type II (Hunter disease): a C1327 to T substitution in the iduronate sulfatase gene.Biochem Biophys Res Commun. 1992 Mar 16;183(2):809-13. doi: 10.1016/0006-291x(92)90555-y. Biochem Biophys Res Commun. 1992. PMID: 1550586
-
Female twin with Hunter disease due to nonrandom inactivation of the X-chromosome: a consequence of twinning.Am J Med Genet. 1992 Dec 1;44(6):834-8. doi: 10.1002/ajmg.1320440625. Am J Med Genet. 1992. PMID: 1481858 Review.
-
Mucopolysaccharidosis type II in females: case report and review of literature.Pediatr Neurol. 2005 Apr;32(4):270-2. doi: 10.1016/j.pediatrneurol.2004.10.009. Pediatr Neurol. 2005. PMID: 15797184 Review.
Cited by
-
Genetic Infiltrative Cardiomyopathies.Heart Fail Clin. 2018 Apr;14(2):215-224. doi: 10.1016/j.hfc.2017.12.003. Heart Fail Clin. 2018. PMID: 29525649 Free PMC article. Review.
-
Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States.Genet Med. 2023 Feb;25(2):100330. doi: 10.1016/j.gim.2022.10.012. Epub 2022 Nov 29. Genet Med. 2023. PMID: 36445366 Free PMC article. Review.
-
Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome).Expert Opin Orphan Drugs. 2017;5(4):295-307. doi: 10.1080/21678707.2017.1296761. Epub 2017 Mar 8. Expert Opin Orphan Drugs. 2017. PMID: 29158997 Free PMC article.
-
Analysis of the IDS gene in 38 patients with Hunter syndrome: the c.879G>A (p.Gln293Gln) synonymous variation in a female create exonic splicing.PLoS One. 2011;6(8):e22951. doi: 10.1371/journal.pone.0022951. Epub 2011 Aug 4. PLoS One. 2011. PMID: 21829674 Free PMC article.
-
Clinical Characteristics and Healthcare Resource Utilization for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review.J Health Econ Outcomes Res. 2022 May 12;9(1):117-127. doi: 10.36469/jheor.2022.33801. eCollection 2022. J Health Econ Outcomes Res. 2022. PMID: 35620452 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials